CardioMend

CardioMend’s heart valve technology is designed to avoid the problems associated with current replacement heart valves, whether mechanical, animal tissue, or human cadaver tissue. Mechanical valves, while durable, require patients to be on lifelong daily anti-coagulation (blood thinning) medication to reduce the risk of blood clotting that might otherwise occur. Animal and cadaver tissue valves usually reduce or eliminate the need for patients to take anti-coagulation medication, but their durability is limited, often because of calcific degeneration or calcium build-up on the foreign tissue leaflets. An immune response to the foreign tissue has been implicated in the limited durability of commercially available tissue valves, which are unsuitable for use in younger patient cohorts, including infants and children.For these reasons, surgeons have begun to favor repair and reconstruction of mitral valves when that option is available. Mitral valve repair can include extension of a valve leaflet with the use of autologous (the patient’s own) pericardial tissue, which has been shown to avoid immunogenic response that could lead to calcific degeneration. But surgeons have not had products or a procedure that would allow them to consistently reconstruct aortic valves using autologous pericardium. Though the concept of reconstructing aortic valves with autologous tissue is not new, it has only been practiced successfully by a few pioneering surgeons using their own freehand techniques.
For the last several years, CardioMend has been dedicated to developing technology that would allow simple, consistent, and reproducible semilunar (aortic and pulmonary) valve reconstruction using autologous pericardium without the need for an implantable device. CardioMend will continue its product development efforts by applying the same reconstruction principles to the atrioventricular (mitral and tricuspid) valves.

Contact Details: 48 Whitehall Avenue Mystic Connecticut 06355 United States of America Tel: 860-572-8531 Fax: Email: info@cardiomend.com. WWW: www.cardiomend.com/

Loading...

CardioMend Patents:
US Patent No.	Title
7208000	Surgical cutting device
6833924	Device and method for testing tissue
6678962	Device and method for assessing the geometry of a heart valve
6425902	Surgical instrument for heart valve reconstruction
6328763	Optimized geometry of a tissue pattern for semilunar heart valve reconstruction
→View more CardioMend patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 291 times since April 2007, the link to the organisation's website has been followed 59 times

Search for more companies in Mystic

Search for more companies in Connecticut

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CardioMend